We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2025
Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2025, which commenced on 10 December 2025. This determination replaces the previous instrument, the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2025
This instrument is updated frequently and there may be a more recent version of the instrument. Ensure you are accessing the current version of the instrument through the Therapeutic Goods Determination page.
A complete list of the 19 changed ingredients is below:
Changed ingredients
| Substance name | Change |
|---|---|
| Lauryl methacrylate/sodium methacrylate crosspolymer dispersion (40 per cent) | Addition |
| Sorbitan distearate | Addition |
| Stearoyl glutamic acid | Addition |
| Nicotinamide mononucleotide | Addition |
| Calcium fructoborate tetrahydrate | Change |
| Cyclocarya paliurus leaf extract dry | Change |
| Artemisia abrotanum | Change |
| Artemisia absinthium | Change |
| Artemisia annua | Change |
| Artemisia arborescens | Change |
| Artemisia argyi | Change |
| Artemisia dracunculus | Change |
| Artemisia frigida | Change |
| Artemisia herba-alba | Change |
| Artemisia maritima | Change |
| Artemisia pallens | Change |
| Artemisia tridentata | Change |
| Artemisia vulgaris | Change |
| Methyl hydrojasmonate | Change |